These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 3136930)
21. Molecular pathology of galactosialidosis in a patient affected with two new frameshift mutations in the cathepsin A/protective protein gene. Richard C; Tranchemontagne J; Elsliger MA; Mitchell GA; Potier M; Pshezhetsky AV Hum Mutat; 1998; 11(6):461-9. PubMed ID: 9603439 [TBL] [Abstract][Full Text] [Related]
22. Protective protein in the bovine lysosomal beta-galactosidase complex. Hiraiwa M; Saitoh M; Arai N; Shiraishi T; Odani S; Uda Y; Ono T; O'Brien JS Biochim Biophys Acta; 1997 Sep; 1341(2):189-99. PubMed ID: 9357958 [TBL] [Abstract][Full Text] [Related]
23. The relation between human lysosomal beta-galactosidase and its protective protein. Hoogeveen AT; Verheijen FW; Galjaard H J Biol Chem; 1983 Oct; 258(20):12143-6. PubMed ID: 6415049 [TBL] [Abstract][Full Text] [Related]
24. The presence of a reduced amount of 32-kd "protective" protein is a distinct biochemical finding in late infantile galactosialidosis. Strisciuglio P; Parenti G; Giudice C; Lijoi S; Hoogeveen AT; d'Azzo A Hum Genet; 1988 Nov; 80(3):304-6. PubMed ID: 3142815 [TBL] [Abstract][Full Text] [Related]
25. Protective protein/cathepsin A loss in cultured cells derived from an early-infantile form of galactosialidosis patients homozygous for the A1184-G transition (Y395C mutation). Itoh K; Shimmoto M; Utsumi K; Mizoguchi N; Miharu N; Ohama K; Sakuraba H Biochem Biophys Res Commun; 1998 Jun; 247(1):12-7. PubMed ID: 9636645 [TBL] [Abstract][Full Text] [Related]
26. Characteristics of the beta-galactosidase-carboxypeptidase complex in GM1-gangliosidosis and beta-galactosialidosis fibroblasts. D'Agrosa RM; Hubbes M; Zhang S; Shankaran R; Callahan JW Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):833-8. PubMed ID: 1497621 [TBL] [Abstract][Full Text] [Related]
27. Early-infantile galactosialidosis: clinical, biochemical, and molecular observations in a new patient. Zammarchi E; Donati MA; Morrone A; Donzelli GP; Zhou XY; d'Azzo A Am J Med Genet; 1996 Aug; 64(3):453-8. PubMed ID: 8862621 [TBL] [Abstract][Full Text] [Related]
28. The role of lysosomal sialidase and beta-galactosidase in processing the complex carbohydrate chains on lysosomal enzymes and possibly other glycoproteins. Swallow DM; West LF; Van Elsen A Ann Hum Genet; 1984 Jul; 48(3):215-21. PubMed ID: 6431895 [TBL] [Abstract][Full Text] [Related]
29. Continuous spectrophotometric assay of human lysosomal cathepsin A/protective protein in normal and galactosialidosis cells. Pshezhetsky AV; Vinogradova MV; Elsliger MA; el-Zein F; Svedas VK; Potier M Anal Biochem; 1995 Sep; 230(2):303-7. PubMed ID: 7503422 [TBL] [Abstract][Full Text] [Related]
30. Direct affinity purification and supramolecular organization of human lysosomal cathepsin A. Pshezhetsky AV; Potier M Arch Biochem Biophys; 1994 Aug; 313(1):64-70. PubMed ID: 8053688 [TBL] [Abstract][Full Text] [Related]
32. Galactosialidosis: molecular heterogeneity among distinct clinical phenotypes. Palmeri S; Hoogeveen AT; Verheijen FW; Galjaard H Am J Hum Genet; 1986 Feb; 38(2):137-48. PubMed ID: 3080874 [TBL] [Abstract][Full Text] [Related]
33. Structure of the lysosomal neuraminidase-beta-galactosidase-carboxypeptidase multienzymic complex. Potier M; Michaud L; Tranchemontagne J; Thauvette L Biochem J; 1990 Apr; 267(1):197-202. PubMed ID: 2109603 [TBL] [Abstract][Full Text] [Related]
34. [Inherited metabolic diseases caused by the genetic defect of protective protein/cathepsin A and lysosomal sialidase]. Itoh K Seikagaku; 2000 Sep; 72(9):1160-4. PubMed ID: 11076198 [No Abstract] [Full Text] [Related]
35. Induction of beta-galactosidase in beta-galactosidase-alpha-neuraminidase deficiency: effects of leupeptin and sucrose. Kato T; Okada S; Yutaka T; Yabuuchi H Biochem Int; 1983 Feb; 6(2):267-73. PubMed ID: 6433925 [TBL] [Abstract][Full Text] [Related]
36. Protective protein as an endogenous endothelin degradation enzyme in human tissues. Itoh K; Kase R; Shimmoto M; Satake A; Sakuraba H; Suzuki Y J Biol Chem; 1995 Jan; 270(2):515-8. PubMed ID: 7822272 [TBL] [Abstract][Full Text] [Related]
37. Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein. Callahan JW Biochim Biophys Acta; 1999 Oct; 1455(2-3):85-103. PubMed ID: 10571006 [TBL] [Abstract][Full Text] [Related]
38. Galactosialidosis: a direct evidence that a 46-kilodalton protein restores deficient enzyme activities in fibroblasts. Nanba E; Tsuji A; Omura K; Suzuki Y Biochem Biophys Res Commun; 1987 Apr; 144(1):138-42. PubMed ID: 3107551 [TBL] [Abstract][Full Text] [Related]
39. Impact of beta-galactosidase mutations on the expression of the canine lysosomal multienzyme complex. Kreutzer R; Kreutzer M; Sewell AC; Techangamsuwan S; Leeb T; Baumgärtner W Biochim Biophys Acta; 2009 Oct; 1792(10):982-7. PubMed ID: 19607915 [TBL] [Abstract][Full Text] [Related]
40. Molecular heterogeneity in human beta-galactosidase and neuraminidase deficiency. Galjaard H; Willemsen R; Hoogeveen AT; Mancini GM; Palmeri S; Verheijen FW; D'Azzo A Enzyme; 1987; 38(1-4):132-43. PubMed ID: 3126043 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]